← Back to Patent Explorer
US5446139A Expired / Lapsed US ⏱️ 0.0 years remaining

Purine analog nucleoside and nucleotide compounds

Assignee: Roche Diagnostics GmbH
•
Filing: 1990-04-23
•
Granted: 1995-08-29
•
Expires: 2010-04-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention concerns nucleoside derivatives of the formula I ##STR1## in which Ba signifies an indolyl (A), benzimidazolyl (B), pyrrolopyridinyl (C), imidazopyridinyl (D), triazolopyrimidinyl (E), imidazotriazinyl (F) or imidazopyrimidinyl (G) group substituted by R 1 , R 2 and R 3 , in which R 1 , R 2 and R 3 , which can be the same or different, signify hydrogen, halogen, a C 1 -C 7 -alkyl, C 2 -C 7 -alkenyl, hydroxy, mercapto, C 1 -C 7 -alkylthio, C 1 -C 7 -alkoxy, C 2 -C 7 -alkenyloxy, ar-C 1 -C 5 -alkyl, ar-C 2 -C 5 -alkenyl, ar-C 1 -C 5 -alkoxy, ar-C 2 -C 5 -alkenyloxy, aryloxy, nitro, amino-C 1 -C 7 -alkyl, C 1 -C 7 -alkylamino-C 1 -C 7 -alkyl, di-C 1 -C 7 -alkylamino-C 1 -C 7 -alkyl, amino, a substituted amino group --NMR 4 or --N(R 4 ) 2 or an imino group --N═CH--R 4 , and R 4 has the meaning given in the description, R 5 , R 6 , R 7 and R 8 each signify hydrogen or one or two of the radicals R 5 , R 6 , R 7 and R 8 a hydroxyl, halogen, cyano, azido or a substituted amino group --NHR 4 or --N(R 4 ) 2 or R 5 and R 7 can together represent a further bond between C-2' and C-3' and Y represents hydrogen or a C 1 -C 7 -alkylcarbonyl, monophosphate, diphosphate or triphosphate group, whereby "aryl" signifies a phenyl or naphthyl group and "hetaryl" a furanyl, thienyl or pyridyl group, as well as their possible anomers, N 7 - or N 9 -regioisomers (purine nomenclature), tautomers and salts.

Inventors

  • 👤 Frank Seela
  • 👤 Werner Bourgeouis
  • 👤 Rainer Gumbiowski
  • 👤 Angelika Roling
  • 👤 Helmut Rosemeyer
  • 👤 Alfred Mertens
  • 👤 Harald Zilch
  • 👤 Bernhard Konig
  • 👤 Edith Koch

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 02:28
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; A; A61; A61P; A61P31/00; A61P31/12

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 595 words
Nucleoside derivatives of formula I ##STR6## wherein Ba is an indolyl (A), benzimidazolyl (B), pyrrolopyridinyl (C), imidazopyridinyl (D), triazolopyrimidinyl (E), imidazotriazinyl (F) or imidazopyrimidinyl (G) group, of the following formulae, respectively: ##STR7## wherein R 1 , R 2 , R 3 , which can be the same or different, are hydrogen, halogen, C 1 -C 7 -alkyl, C 2 -C 7 -alkenyl, hydroxy, mercapto, C 1 -C 7 -alkylthio, C 1 -C 7 -alkoxy, C 2 -C 7 -alkenyloxy, aryl-C 1 -C 5 -alkyl, aryl-C 2 -C 5 -alkenyl, aryl-C 1 -C 5 -alkoxy, aryl-C 2 -C 5 -alkenyloxy, aryloxy, nitro, amino-C 1 -C 7 -alkyl, C 1 -C 7 -alkylamino-C 1 -C 7 -alkyl, di-C 1 -C 7 -alkylamino-C 1 -C 7 -alkyl, amino, substituted amino group of the formula --NHR 4 or --N(R 4 ) 2 or an imino group --N═CH--R 4 , wherein R 4 is C 1 -C 7 -alkyl, C 2 -C 7 -alkenyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 7 -alkyl, C 3 -C 7 -cycloalkenyl, C 1 -C 7 -alkoxy-C 1 -C 7 -alkyl, halogen-C 1 -C 7 -alkyl, hydroxy-C 1 -C 7 -alkyl, aryl-C.sub. 1 -C 5 -alkyl, aryl-C 2 -C 5 -alkenyl, hetaryl-C 1 -C 5 -alkyl or hetaryl-C 2 -C 5 -alkenyl radical, wherein the aryl and hetaryl moieties are unsubstituted or are substituted one, two or three times by C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 1 -C 6 -alkoxy, halogen or hydroxyl, or R 4 is amino-C 1 -C 7 -alkyl, C 1 -C 7 -alkylamino-C 1 -C 7 -alkyl or di-C 1 -C 7 -alkylamino-C 1 -C 7 -alkyl and, in the case of the --NHR 4 and --N═CH--R 4 groups, R 4 can additionally be amino, C 1 -C 7 -alkylamino, di-C 1 -C 7 -alkylamino or C 1 -C 7 -alkoxy or, in the case of the --N(R 4 )2 group, the two nitrogen substituents R 4 together can form a C 1 -C 7 -alkylidene group which, in turn, can be unsubstituted or substituted by C 1 -C 7 -alkoxy, C 1 -C 7 -alkylamino or di-C 1 -C 7 -alkylamino, wherein said aryl is phenyl or naphthyl and said hetaryl is furanyl, thienyl or pyridyl, R 5 , R 6 , R 7 , and R 8 each are hydrogen, or one or two of R 5 , R 6 , R 7 , and R 8 are hydroxyl, halogen, cyano, azido or a substituted amino group --NHR 4 or --N(R 4 ) 2 , or and R 5 and R 7 can together represent a further bond between C-2' and C-3', and Y is hydrogen or C 1 -C 7 -alkylcarbonyl, monophosphate, diphosphate or triphosphate, with the provisos that a) when R 6 is a hydroxyl group, R 8 is other than a hydrogen atom or a hydroxyl group, b) when Ba is the group (B) , R 6 is other than a halogen, amino or azido group, c) when Ba is the group (D) and R 2 is hydrogen, R 1 is other than chlorine or amino and R 6 is other than hydrogen or chlorine, and d) When Ba is the group (E) and R 1 is amino, R 5 and R 7 cannot together represent a bond, as well as their possible α and β-anomers, , N 7 -, N 8 - or N 9 regioisomers (purine nomenclature), tautomers and salts, and nucleic acids which contain compounds of the formula I as constructional units.
Claim 2
Dependent Claim 595 words
Nucleoside derivatives of formula I ##STR6## wherein Ba is an indolyl (A), benzimidazolyl (B), pyrrolopyridinyl (C), imidazopyridinyl (D), triazolopyrimidinyl (E), imidazotriazinyl (F) or imidazopyrimidinyl (G) group, of the following formulae, respectively: ##STR7## wherein R 1 , R 2 , R 3 , which can be the same or different, are hydrogen, halogen, C 1 -C 7 -alkyl, C 2 -C 7 -alkenyl, hydroxy, mercapto, C 1 -C 7 -alkylthio, C 1 -C 7 -alkoxy, C 2 -C 7 -alkenyloxy, aryl-C 1 -C 5 -alkyl, aryl-C 2 -C 5 -alkenyl, aryl-C 1 -C 5 -alkoxy, aryl-C 2 -C 5 -alkenyloxy, aryloxy, nitro, amino-C 1 -C 7 -alkyl, C 1 -C 7 -alkylamino-C 1 -C 7 -alkyl, di-C 1 -C 7 -alkylamino-C 1 -C 7 -alkyl, amino, substituted amino group of the formula --NHR 4 or --N(R 4 ) 2 or an imino group --N═CH--R 4 , wherein R 4 is C 1 -C 7 -alkyl, C 2 -C 7 -alkenyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 7 -alkyl, C 3 -C 7 -cycloalkenyl, C 1 -C 7 -alkoxy-C 1 -C 7 -alkyl, halogen-C 1 -C 7 -alkyl, hydroxy-C 1 -C 7 -alkyl, aryl-C.sub. 1 -C 5 -alkyl, aryl-C 2 -C 5 -alkenyl, hetaryl-C 1 -C 5 -alkyl or hetaryl-C 2 -C 5 -alkenyl radical, wherein the aryl and hetaryl moieties are unsubstituted or are substituted one, two or three times by C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 1 -C 6 -alkoxy, halogen or hydroxyl, or R 4 is amino-C 1 -C 7 -alkyl, C 1 -C 7 -alkylamino-C 1 -C 7 -alkyl or di-C 1 -C 7 -alkylamino-C 1 -C 7 -alkyl and, in the case of the --NHR 4 and --N═CH--R 4 groups, R 4 can additionally be amino, C 1 -C 7 -alkylamino, di-C 1 -C 7 -alkylamino or C 1 -C 7 -alkoxy or, in the case of the --N(R 4 )2 group, the two nitrogen substituents R 4 together can form a C 1 -C 7 -alkylidene group which, in turn, can be unsubstituted or substituted by C 1 -C 7 -alkoxy, C 1 -C 7 -alkylamino or di-C 1 -C 7 -alkylamino, wherein said aryl is phenyl or naphthyl and said hetaryl is furanyl, thienyl or pyridyl, R 5 , R 6 , R 7 , and R 8 each are hydrogen, or one or two of R 5 , R 6 , R 7 , and R 8 are hydroxyl, halogen, cyano, azido or a substituted amino group --NHR 4 or --N(R 4 ) 2 , or and R 5 and R 7 can together represent a further bond between C-2' and C-3', and Y is hydrogen or C 1 -C 7 -alkylcarbonyl, monophosphate, diphosphate or triphosphate, with the provisos that a) when R 6 is a hydroxyl group, R 8 is other than a hydrogen atom or a hydroxyl group, b) when Ba is the group (B) , R 6 is other than a halogen, amino or azido group, c) when Ba is the group (D) and R 2 is hydrogen, R 1 is other than chlorine or amino and R 6 is other than hydrogen or chlorine, and d) When Ba is the group (E) and R 1 is amino, R 5 and R 7 cannot together represent a bond, as well as their possible α and β-anomers, , N 7 -, N 8 - or N 9 regioisomers (purine nomenclature), tautomers and salts, and nucleic acids which contain compounds of the formula I as constructional units.
Claim 3
Dependent Claim 55 words
Nucleoside of claim 1, wherein R 1 is hydrogen, amino, C 1 -C 6 -alkoxy, halogen or nitro, R 2 is hydrogen, halogen or amino, R 3 is hydrogen and R 5 -R 8 are hydrogen atoms, or R 6 and R 8 are hydrogen and R 5 and R 7 together form a bond.
Claim 4
Dependent Claim 53 words
Nucleoside of claim 1, wherein Ba is group (A), R 1 is amino or nitro and R 2 R 3 , and R 5 -R 8 are each hydrogen or R 2 , R 3 , R 6 and R 8 are hydrogen and R 5 and R 7 together form a bond.
Claim 5
Dependent Claim 23 words
Nucleoside of claim 1, wherein Ba is group (B) and R 1 , R 2 and R 5 -R 8 are each hydrogen.
Claim 6
Dependent Claim 54 words
Nucleoside of claim 1, wherein Ba is group (C), R 1 is hydrogen, amino or nitro, and R 2 , R 3 , R 5 -R 8 each are hydrogen, or R 2 , R 3 , R 6 and R 8 are hydrogen and R 5 and R 7 together form a bond.
Claim 7
Dependent Claim 27 words
Nucleoside of claim 1, wherein Ba is group (D) and R 1 is amino or chlorine, and R 2 and R 5 -R 8 each are hydrogen.
Claim 8
Dependent Claim 30 words
Nucleoside of claim 1, wherein Ba is group (E), R 1 is amino or C 1 -C 6 -alkoxy and R 2 and R 5 -R 8 each are hydrogen.
Claim 9
Dependent Claim 27 words
Nucleoside of claim 1, wherein Ba is group (F) , R 2 is hydrogen or amino and R 3 and R 5 -R 8 are each hydrogen.
Claim 10
Dependent Claim 28 words
Nucleoside of claim 1, wherein Ba is group (G) , R 2 is hydrogen, amino or chlorine and R 3 and R 5 -R 8 are each hydrogen.
Claim 11
Dependent Claim 18 words
Nucleotide of claim 1, wherein said nucleotide is 1-(2,3-didesoxy-β-D-glyceropentofuranosyl)-1 H-pyrrolo-[2,3-b]pyridine 5 1 -triphosphate or 1-(2,3-didesoxy-β-D-glyceropent-2-enofuranosyl)-4-nitro-1H-pyrrolo[2,3-b]pyridine 5 1 -triphosphate.
Claim 12
Dependent Claim 15 words
Nucleotide of claim 10, wherein said nucleotide is in the form of the triethylammonium salt.
Claim 13
Dependent Claim 129 words
Nucleoside derivative of formula I ##STR8## wherein Ba is an indolyl, pyrrolopyridinyl, imidazopyridinyl, imidazotriazinyl or imidazopyrimidinyl group; R 1 is hydrogen, amino, C1-C6-alkoxy, halogen or nitro; R 2 is hydrogen, halogen or amino; R 3 is hydrogen; R 5 is hydrogen; R 6 is hydrogen, halogen, cyano or azido; R 7 is hydrogen; and R 8 is hydrogen or R 5 and R 7 together form a bond; with the proviso that when Ba is the group (E) and R 1 is amino, R 5 and R 7 cannot together represent a bond, as well as their possible α and β-anomers, N 7 -, N 8 - or N 9 regioisomers (purine nomenclature), tautomers and salts, and nucleic acids which contain compounds of the formula I as constructional units.
Claim 14
Dependent Claim 129 words
Nucleoside derivative of formula I ##STR8## wherein Ba is an indolyl, pyrrolopyridinyl, imidazopyridinyl, imidazotriazinyl or imidazopyrimidinyl group; R 1 is hydrogen, amino, C1-C6-alkoxy, halogen or nitro; R 2 is hydrogen, halogen or amino; R 3 is hydrogen; R 5 is hydrogen; R 6 is hydrogen, halogen, cyano or azido; R 7 is hydrogen; and R 8 is hydrogen or R 5 and R 7 together form a bond; with the proviso that when Ba is the group (E) and R 1 is amino, R 5 and R 7 cannot together represent a bond, as well as their possible α and β-anomers, N 7 -, N 8 - or N 9 regioisomers (purine nomenclature), tautomers and salts, and nucleic acids which contain compounds of the formula I as constructional units.

References Cited (Backward Citations)

GB696952A Cited
GB1176419A Cited
GB1474299A Cited
EP0038569A2 Cited
EP0043722A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-08-28 1999-02-27 1999-08-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-08-28 2003-02-27 2003-08-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-08-28 2007-02-27 2007-08-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag